ERG and cancer: Deletions of 12p were found in 14.4% and 16.0% of ERG-negative cancers (according to ERG IHC and FISH analysis), and in 13.7% (IHC, p = 0.5626) and 16.0% (FISH, p = 0.9790) of ERG-positive cancers (Figure 1).